Pancreatic duct stenting to prevent post-ERCP pancreatitis: A systematic review and meta-analysis of randomized controlled trials
Pancreatology · 2026-08 · 26 (5) · 672-685
DOI: 10.1016/j.pan.2026.04.006 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Pancreatology, 2026-08. Verfasst von Mohamed Abdulla Ghuloom Abdulla Bucheeri und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Stents, Pancreatitis, Cholangiopancreatography, Endoscopic Retrograde, Pancreatic Ducts. Die Arbeit nennt 39 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Prophylactic pancreatic duct (PD) stenting has been proposed to mitigate the risk of post-ERCP pancreatitis (PEP), particularly in high-risk populations. The aim of this study was to systematically review the evidence of the efficacy of prophylactic PD stenting in reducing the incidence of PEP in patients undergoing ERCP, including subgroup analyses of high-risk and average risk populations. METHODS: A systematic review and meta-analysis were conducted according to PRISMA guidelines. Randomized controlled trials (RCTs) evaluating prophylactic PD stenting versus no stenting in adults undergoing ERCP were included. The primary outcome was incidence of PEP. Secondary outcomes included PEP incidence in high-risk subgroups, adverse events unrelated to PEP, mortality. RESULTS: Eighteen RCTs comprising 4637 participants (2380 in the stent group and 2257 in the no-stent group) were included. Prophylactic PD stenting significantly reduced the risk of PEP compared to no stenting (pooled OR 0.35, 95% CI 0.23 to 0.54, p < 0.05), with moderate heterogeneity (I2 = 66.9%). In the subgroup analysis, stenting reduced PEP risk in high-risk and average-risk populations (pooled OR 0.37, 95% CI 0.20 to 0.66, p-value = 0.0009; I2 = 76.9% and pooled OR 0.34, 95% CI: 0.18 to 0.63; p = 0.0006; I2 = 46.8%). The pooled odds ratio of adverse events unrelated to PEP was low (odds ratio is 1 with a 95% confidence interval of 0.21 - 4.85.), and mortality rates did not differ between groups (OR of 0.43 and a 95% CI of 0.09 to 2.09). CONCLUSION: Prophylactic PD stenting appears to significantly reduce the risk of PEP, in both high- and average-risk patients. However, considerable heterogeneity and methodological limitations across studies highlight the need for future trials to refine patient selection, stent characteristics and combination of prophylactic strategies. PROSPERO: CRD420250652709.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
- Department of Medicine, Western University, Ontario, Canada; McMaster University, Hamilton, Canada.
- Division of Gastroenterology and Digestive Endoscopy, Humanitas Research Hospital - IRCCS, Via Manzoni 56, 20089, Rozzano, Milano, Italy.
- Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Quebec, Canada.
- Division of Gastroenterology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada; Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada. Electronic address: natalia.calo@…
Zitieren
APA
Bucheeri, M. A. G. A., Khalaf, K., Yuan, Y., Nishimura, T., Li, H., Zheng, K., Hu, M., Jayawardena, R., Spadaccini, M., Teshima, C. W., Mosko, J. D., Chen, Y. I., Repici, A., May, G. R., & Calo, N. C. (2026). Pancreatic duct stenting to prevent post-ERCP pancreatitis: A systematic review and meta-analysis of randomized controlled trials. Pancreatology, 26(5), 672-685. https://doi.org/10.1016/j.pan.2026.04.006
Vancouver
Bucheeri MAGA, Khalaf K, Yuan Y, Nishimura T, Li H, Zheng K, et al. Pancreatic duct stenting to prevent post-ERCP pancreatitis: A systematic review and meta-analysis of randomized controlled trials. Pancreatology. 2026;26(5):672-685. doi:10.1016/j.pan.2026.04.006
BibTeX
@article{Bucheeri2026,
author = {Bucheeri, Mohamed Abdulla Ghuloom Abdulla and Khalaf, Kareem and Yuan, Yuhong and Nishimura, Tomoyuki and Li, Huaqi and Zheng, Katina and Hu, Malini and Jayawardena, Reyana and Spadaccini, Marco and Teshima, Christopher W and Mosko, Jeffrey D and Chen, Yen-I and Repici, Alessandro and May, Gary R and Calo, Natalia Causada},
title = {Pancreatic duct stenting to prevent post-ERCP pancreatitis: A systematic review and meta-analysis of randomized controlled trials},
journal = {Pancreatology},
year = {2026},
volume = {26},
number = {5},
pages = {672--685},
doi = {10.1016/j.pan.2026.04.006}
}
EUVIMED